Jennifer,
This is risky territory. How long has she been in remission and what is the evidence that she has been cleared of breast cancer?
The studies that look at tesamorelin in kaposi sarcoma show regression of tumor burden, so there is evidence that these agents may be anti-carcinogenic. Tesamorelin is a different compound than CJC/Ipammorelin and can we extrapolate the studies to both? Maybe, but the general uninformed opinion about these agents is that they all function like hGH. If she has any return of cancer, the oncologists and other physicians will be blame it on the use of CJC/Ipamorelin and that puts you at substantial medical legal risk.
hope this helps
Abid